• Home
  • Outcomes by Candida spp. in the ReSTORE Phase 3 Trial of Rezafungin Versus Caspofungin for Candidemia and/or Invasive Candidiasis

Outcomes by Candida spp. in the ReSTORE Phase 3 Trial of Rezafungin Versus Caspofungin for Candidemia and/or Invasive Candidiasis

*The ATCC Licensed Derivative Emblem, the ATCC Licensed Derivative word mark and the ATCC catalog marks are trademarks of ATCC. Microbiologics, Inc. is licensed to use these trademarks and to sell products derived from ATCC® cultures. Look for the ATCC Licensed Derivative © Emblem for products derived from ATCC© cultures.